Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial)

OBJECTIVE: In the ANRS 139 TRIO trial, the use of 3 new active drugs (raltegravir, etravirine, and darunavir/ritonavir), resulted in a potent and sustained inhibition of viral replication in multidrug-resistant treatment-experienced patients. The aim of this virological sub-study of the ANRS 139 TRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Charpentier, Charlotte, Fagard, Catherine, Colin, Céline, Katlama, Christine, Molina, Jean-Michel, Jacomet, Christine, Visseaux, Benoit, Taburet, Anne-Marie, Brun-Vézinet, Françoise, Chêne, Geneviève, Yazdanpanah, Yazdan, Descamps, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547918/
https://www.ncbi.nlm.nih.gov/pubmed/23349724
http://dx.doi.org/10.1371/journal.pone.0053621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547918/
https://www.ncbi.nlm.nih.gov/pubmed/23349724
http://dx.doi.org/10.1371/journal.pone.0053621

Ejemplares similares